Articles
-
Kemwell Biopharma Brochure
3/29/2012
Kemwell Biopharma will offer services ranging from full-service process development, manufacture, formulation and fill and finish at the cGMP manufacturing facility in Bangalore, India as a one-stop-shop through access to Boehringer Ingelheim's® cell line development with the BI HEX technology platform, followed by a preferred access to the large-scale commercial production of Boehringer Ingelheim at its facilities in Europe.
-
Sterile Clinical Trial Material Formulation & Filling
3/26/2012
DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
-
Cytotoxic Formulation & Filling
3/26/2012
DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.
-
Brochure: Finished Dosage Forms
2/21/2012
DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
-
Track And Trace In China
2/9/2012
Track and trace technology has significant value for both industry and society. Both Chinese industry and the government are increasing efforts to promote the establishment of a reliable, safe traceability system. By Yuxiang Zhang
-
Brochure: Pharma Sterile Dosage Forms
1/30/2012
DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields.
-
Preparation Of MUPS (Multiple Unit Particles System) Tablet Using Celphereâ„¢ And Preliminary Blend Of Microcrystalline Cellulose And Pregelatinized Starch
12/2/2011
Multiple dosage forms (Pellets, Capsule, MUPS tablet etc.) show better reproducibility of the drug absorption in the body than single dosage form (Matrix tablet).
-
The Case For The Use Of Point-Of-Care Testing In Pharmaceutical Clinical Trials
11/22/2011
Clinical trials that are designed to evaluate the efficacy of novel pharmaceuticals require a variety of diagnostic tests to be performed on all enrolled patients.
-
Greg Weilersbacher's Expert Advice On Selecting A CMO
11/11/2011
Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent — to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. By Rob Wright
-
White Paper: Clinical Trial Material Production And Testing: What Your CMO Is Not Telling You
6/7/2011
Manufacturing clinical trial material (CTM), and the costs for the associated fill/finish and release work, most likely are not the costliest portions of the pharmaceutical process chain. By Alexander Mello, Director, Project Management